Patents Examined by Raymond Henley, II
  • Inhibition of neovascularization by simultaneous inhibition of prostanoid IP and EP4 receptors
    Patent number: 9295665
    Abstract: There are provided inter alia methods and compounds useful for decreasing neovascularization (e.g., choroidal neovascularization) in a subject in need thereof.
    Type: Grant
    Filed: March 5, 2014
    Date of Patent: March 29, 2016
    Assignee: ALLERGAN, INC.
    Inventors: Jenny W. Wang, David F. Woodward
  • Fluid therapy with L-lactate and/or pyruvate anions
    Patent number: RE38604
    Abstract: Electrolyte solutions are provided which are useful in electrolyte and fluid therapy, parenteral nutrition and dialysis. The Na:Cl ratio is normalized, plasma and cellular pH are normalized and cellular cofactor ratios are normalized in a manner which decreases toxicity over prior art solutions.
    Type: Grant
    Filed: February 1, 2002
    Date of Patent: September 28, 2004
    Assignee: BTG International Limited
    Inventor: Richard L. Veech